Patent Assignment
Reel/Frame 048945/0465
Change of Name
Recorded: 2019-04-18
Pages: 4
Assignor
SANGAMO BIOSCIENCES, INC.
Executed: 2017-01-05
Assignee
SANGAMO THERAPEUTICS, INC.
501 CANAL BLVD., SUITE A100, RICHMOND, CALIFORNIA, 94804
Covered Property
(1)
A Method of Treating Factor Ix Deficiency Using Nuclease-Mediated Targeted Integration
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.